Results 181 to 190 of about 89,877 (216)

Pharmacological inhibition of NMDA receptors reduces migration and viability in triple-negative inflammatory breast cancer cell lines. [PDF]

Discov Oncol
Mendez-Santacruz LL, Bittman-Soto XS, Molina-Nieves A, Maldonado-Vlaar CS, Peterson-Peguero E.   +4 more
europepmc   +1 more source

A population-based analysis of a risk stratification system for predicting radiotherapy benefits in invasive breast carcinoma of no special type with medullary pattern. [PDF]

Eur J Med Res
Zhang J, Wang L, Chen H, Yan Y, Ge G, Wang K, He J.   +6 more
europepmc   +1 more source

The role of body mass index at diagnosis in patients with inflammatory breast cancer. [PDF]

Breast
Borremans K, Nguyen HL, De Schepper M, Lerebours F, Vion R, Clatot F, Berghian A, Maetens M, Isnaldi E, Molinelli C, Lambertini M, Grillo F, Zoppoli G, Dirix L, Punie K, Wildiers H, Smeets A, Nevelsteen I, Neven P, Vincent-Salomon A, Larsimont D, Duhem C, Viens P, Bertucci F, Biganzoli E, Vermeulen P, Floris G, Richard F, Desmedt C.   +28 more
europepmc   +1 more source

A phase Ib/II trial of neoadjuvant neratinib added to standard therapy in patients with HER2-positive or HR-positive/HER2-negative inflammatory breast cancer (including stage III and IV disease). [PDF]

Ther Adv Med Oncol
Lim B, Marx A, Kai M, Alexander A, Bassett R, Ma W, Willey J, Sun H, Nasrazadani A, Mohammad MM, Zhang J, Lucci A, Sun SX, Stauder MC, Whitman GJ, Le-Petross H, Valero V, MDACC Inflammatory Breast Cancer Team, Woodward WA, Layman RM.   +19 more
europepmc   +1 more source

Urogenital microbiome, intracellular bacterial communities, and their contribution to urinary tract infections. [PDF]

Microbiol Spectr
Robino L, Navarro N, Canales-Huerta N, González MJ, Cruz E, Sauto R, Morales C, Neffa F, Zeballos J, Jessen GL, Zunino P, Scavone P.   +11 more
europepmc   +1 more source

A comparison of risk factors for interval and screen-detected breast cancers: a case-case analysis of the Breast Cancer Now Generations Cohort, UK

Johns L, Brayley M, Frost R, Coulson P, Jones M, de Gonzalez AB, Garcia-Closas M.   +6 more
europepmc   +1 more source

Ultrasound-based DenseNet201 outperforms breast imaging reporting and data system and ResNet50 in predicting HER2 status in invasive breast cancer. [PDF]

Am J Transl Res
Wu L, Zhou X, Ye X, Chen F, Liang T, Liu K.   +5 more
europepmc   +1 more source

Evaluating double-reading mammography for long-term surveillance in breast cancer survivors: a retrospective exploratory analysis from a single center. [PDF]

Radiol Med
Vatteroni G, Trimboli RM, Fici F, Bolengo I, Pinna G, Pruneddu G, Salpietro E, Nardi P, Turri N, Gentile D, Tinterri C, Bernardi D.   +11 more
europepmc   +1 more source

Exome sequencing reveals new insights into the germline landscape of inflammatory breast cancer among Tunisian patients. [PDF]

J Transl Med
Boujemaa M, Hamdi Y, Guidara S, Souissi A, Bouaziz H, Mejri N, Aloulou S, Mahjoub N, Chaabane K, Hakim H, Boussen H, Dhiab TB, Kamoun S, Ayadi R, Driss M, Ayadi A, Radouani F, Fakhkhari M, Khyatti M, Abdelhak S, Sadki K, Boubaker MS, Rebai A, Cherif B.   +23 more
europepmc   +1 more source